Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12618000460202
Ethics application status
Approved
Date submitted
22/03/2018
Date registered
29/03/2018
Date last updated
10/08/2018
Type of registration
Prospectively registered
Titles & IDs
Public title
vSHADE - An internet-delivered, evidenced-based treatment program for mental health and alcohol use in contemporary Veterans
Query!
Scientific title
An internet-delivered, evidenced-based treatment program for mental health and alcohol use in contemporary Veterans - SHADE
Query!
Secondary ID [1]
294393
0
University of Newcastle - G1600670
Query!
Universal Trial Number (UTN)
U1111-1211-2026
Query!
Trial acronym
vSHADE
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Depression
307138
0
Query!
Alcohol Use Disorder
307139
0
Query!
Condition category
Condition code
Mental Health
306259
306259
0
0
Query!
Depression
Query!
Mental Health
306260
306260
0
0
Query!
Addiction
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Participants will all have online access to the SHADE program (10 modules) for a period of 12 weeks. SHADE was developed by our team and is the first evidence-based internet-delivered cognitive behavioural therapy (CBT) treatment for comorbid depression and alcohol/other drug use problems, which has been evaluated relative to extended face-to-face traditional cognitive behaviour therapy (CBT) in two randomised controlled trials.
Half of the participants will be randomly allocated to also have access to the Breathing Space social network for a period of 12 weeks. Breathing Space is a private, closed, purpose-built social networking app, developed and designed by our research group. Only participants in this project, and research staff will have access to the closed group. The site will be moderated by research staff, including Clinical Psychologists and Psychologists.
SHADE is a 10 module CBT intervention which participants can complete at their own pace and discretion. Each module should take around an hour to complete. As with traditional therapist delivered CBT, SHADE computer modules are delivered according to the following structure: setting the agenda for the current session, reviewing homework activities, learning/developing new skills, assigning homework and conclusion.
Module 1 includes an Introduction of 5-10 minutes that orients the person to the computer program, shows them how to use the mouse and keyboard, and teaches them how to navigate their way through the program. In Module 1 participants will: Learn to examine their own story and learn how to evaluate life events (“hurdles and ladders”) that have led to their current situation; Learn important information about alcohol, drugs and depression; and begin to learn how to identify the pros and cons of using.
In Module 2, participants will In this session, clients will: learn to develop an activity log, to monitor the things they are currently doing in everyday life; learn to examine the costs of drinking/using (including job, finances, personal, health); and learn about “mindful awareness”.
In Module 3, participants will: learn how thoughts and behaviours are linked; learn to analyse pros and cons balance in regard to changing their situation; and learn to experience routine activities in a mindful way.
In Module 4, participants will: learn to use their “activity log” to schedule one pleasant and one achievement activity into each day; learn more about their experience of cravings and impulses; and develop a plan for changing their current situation.
In Module 5, participants will: learn about problematic patterns of thinking common to depression and using alcohol/other drug; learn to manage these problematic patterns; and develop mindfulness skills.
In this Module 6, participants will: learn problem solving skills; and develop mindfulness skills.
In Module 7 participants will: learn about the concept of a schema; identify their own problematic schema; and learn how to develop an alternative, more balanced schema.
In Module 8, participants will: learn how to use mindfulness as a strategy to help cope with unpleasant thoughts, feelings and events; learn the skills to effective refuse offers of alcohol/other drug; and develop and emergency craving plan to help manage real-life high-risk situations for alcohol/other drug use.
In Module 9, participants will: start to prepare for life outside of SHADE therapy; learn about “seemingly irrelevant decisions”; learn to identify and manage the ”breaking the rule” effect; and learn how to look after their wellbeing.
In Module 10, participants will: learn about the importance of relapse prevention; and develop their own relapse management and prevention plan.
Participant adherence to the intervention will be monitored through website analytics that provide details about frequency and duration of log ins and pages visited for each participant.
Breathing Space is a purpose built social networking app where participants who are allocated into the SHADE + Breathing Space intervention of the vSHADE project can obtain support and encouragement from other people who are interested in making changes to their drinking and Depression. It is an opportunity for participants to discuss things that they have learned during the vSHADE project, ask questions and share/receive useful information from others in a safe and supportive environment. This is done through status updates, longer posts and replies to posts from other participants.
Breathing Space is a private social networking site, and as such, only participants who have been allocated to the SHADE + Breathing Space intervention can participate. The site and any of its contents will not be publically visible on the internet and can only be viewed by participants and clinical research staff employed on the project.
Eligible participants of the vSHADE study will be given access to the Breathing Space social networking app for a period of 12 weeks. The site is available 24 hours, and participants can write a post anytime. However, it is made clear that the site is not monitored by the Clinical Psychologist moderators 24/7, and that they are only available to help with any immediate concerns in normal working hours (Mon-Fri 9am-5pm), and therefore, if participants are in a crisis, they are to use the emergency numbers provided on the Crisis tab.
There is no maximum or minimum frequency or duration of participation however participants will receive weekly e-mail or SMS (as per their preference) reminders about the vSHADE study. The number of participants using Breathing Space at any given time will vary between 1-75 plus the research team and site moderators who will also post. Usage of the site will be measured using computer analytics.
Query!
Intervention code [1]
300695
0
Treatment: Other
Query!
Comparator / control treatment
The control Evidence based SHADE treatment is being compared to SHADE with Breathing Space social networking support.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
305264
0
The Depression, Anxiety, Stress Scale (DASS-21) is a 21 item self-report measurement of depression, anxiety and stress.
Query!
Assessment method [1]
305264
0
Query!
Timepoint [1]
305264
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Primary outcome [2]
305265
0
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item screening tool developed by the World Health Organization (WHO) to assess alcohol consumption, drinking behaviors, and alcohol-related problems.
Query!
Assessment method [2]
305265
0
Query!
Timepoint [2]
305265
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Primary outcome [3]
305266
0
The Opiate Treatment Index (OTI) - Alcohol scale is a self-report measure which asks about the quantity of alcohol consumed and date of consumption of the last three occasions of alcohol use within the past month. This information is used to estimate the average daily amount of alcohol consumed in the last month.
Query!
Assessment method [3]
305266
0
Query!
Timepoint [3]
305266
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [1]
344657
0
Quality of Life will be assessed by the EUROHIS-QOL 8-item index.
Query!
Assessment method [1]
344657
0
Query!
Timepoint [1]
344657
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [2]
344658
0
Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ),
Query!
Assessment method [2]
344658
0
Query!
Timepoint [2]
344658
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [3]
344660
0
The Fagerström Test for Nicotine Dependence will be used to assess the intensity of physical addiction to nicotine. The test was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence.
Query!
Assessment method [3]
344660
0
Query!
Timepoint [3]
344660
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [4]
344939
0
The Opiate Treatment Index (OTI) - Tobacco, which asks about the quantity and mode of tobacco, used and date of consumption of the last three occasions of use within the past month. This information is used to estimate the average daily amount of tobacco, used in the last month.
Query!
Assessment method [4]
344939
0
Query!
Timepoint [4]
344939
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [5]
344940
0
The Opiate Treatment Index (OTI) – Cannabis scale, which asks about the quantity and mode of cannabis used and date of consumption of the last three occasions of use within the past month. This information is used to estimate the average daily amount of cannabis used in the last month.
Query!
Assessment method [5]
344940
0
Query!
Timepoint [5]
344940
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [6]
344941
0
The Opiate Treatment Index (OTI) - Amphetamines scale, which asks about the quantity and mode of amphetamines used and date of consumption of the last three occasions of use within the past month. This information is used to estimate the average daily amount of amphetamines used in the last month.
Query!
Assessment method [6]
344941
0
Query!
Timepoint [6]
344941
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Secondary outcome [7]
344942
0
Drug Use History will be measured by self report of first occasion, last occasion and frequency of use of a range of substances.
Query!
Assessment method [7]
344942
0
Query!
Timepoint [7]
344942
0
12 weeks (post baseline assessment and commencement of treatment)
Query!
Eligibility
Key inclusion criteria
Have served in the Australian Defence Forces (Army, Airforce and/or Navy);
Not currently serving (i.e. a veteran);
Current depressive symptoms measured by a DASS-21 score greater or equal to 6;
Current alcohol misuse measured by the AUDIT-C score greater or equal to 3.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
45
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Not having regular access to the internet;
Not having served in the armed forces;
Still serving in the armed forces.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealment will be ensured by central randomisation using a computer.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using computer sequence generation.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
150 participants will be recruited, with 75 in each experimental condition.
Descriptive and between groups analyses will be carried out.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
2/04/2018
Query!
Actual
2/07/2018
Query!
Date of last participant enrolment
Anticipated
1/11/2018
Query!
Actual
Query!
Date of last data collection
Anticipated
1/02/2019
Query!
Actual
Query!
Sample size
Target
150
Query!
Accrual to date
3
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Query!
Funding & Sponsors
Funding source category [1]
299028
0
Charities/Societies/Foundations
Query!
Name [1]
299028
0
Defence Health Foundation
Query!
Address [1]
299028
0
PO Box 7518
Melbourne
Victoria 3004
Query!
Country [1]
299028
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
University Drive
Callaghan
NSW 2038
Query!
Country
Australia
Query!
Secondary sponsor category [1]
298253
0
None
Query!
Name [1]
298253
0
Query!
Address [1]
298253
0
Query!
Country [1]
298253
0
Query!
Other collaborator category [1]
280041
0
Commercial sector/Industry
Query!
Name [1]
280041
0
ASPEN Medical
Query!
Address [1]
280041
0
Suite 17C
2 King St
Deakin
ACT 2600
Query!
Country [1]
280041
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
299963
0
Department of Veterans' Affairs Human Research Ethics Committee
Query!
Ethics committee address [1]
299963
0
CP3-6-036 Campbell Park Offices PO Box 7912 Canberra BC ACT 2610
Query!
Ethics committee country [1]
299963
0
Australia
Query!
Date submitted for ethics approval [1]
299963
0
24/01/2017
Query!
Approval date [1]
299963
0
01/06/2017
Query!
Ethics approval number [1]
299963
0
E017/001
Query!
Ethics committee name [2]
299994
0
University of Newcastle Human Research Ethics Committee
Query!
Ethics committee address [2]
299994
0
Research & Innovation Services Research Integrity Unit NIER, Block C The University of Newcastle Callaghan NSW 2308
Query!
Ethics committee country [2]
299994
0
Query!
Date submitted for ethics approval [2]
299994
0
14/06/2017
Query!
Approval date [2]
299994
0
29/06/2017
Query!
Ethics approval number [2]
299994
0
H-2017-0179
Query!
Summary
Brief summary
The mental health and well-being of serving and ex-serving Australian Defence Force (ADF) personnel is of paramount importance, with a recent national audit indicating mental health disorders including depression, anxiety, post-traumatic stress, substance use, and suicide, are a major cause of reduced quality of life for many members, with direct impacts on their families. SHADE is a 10-session internet delivered program which has demonstrated effectiveness in the general population for reduction of depressive symptoms and hazardous alcohol use. This study will pilot and evaluate the use of the SHADE program amongst ex-serving ADF personnel with and without the addition of a psychologist moderated social netoworking site, "Breathing Space."
Query!
Trial website
https://vshade.com.au/
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
82102
0
A/Prof Frances Kay-Lambkin
Query!
Address
82102
0
University of Newcastle
School of Medicine and Public Health
CBMHR
PO Box 833
Newcastle
NSW 2300
Query!
Country
82102
0
Australia
Query!
Phone
82102
0
+61 416204031
Query!
Fax
82102
0
Query!
Email
82102
0
[email protected]
Query!
Contact person for public queries
Name
82103
0
Frances Kay-Lambkin
Query!
Address
82103
0
University of Newcastle
School of Medicine and Public Health
CBMHR
PO Box 833
Newcastle
NSW 2300
Query!
Country
82103
0
Australia
Query!
Phone
82103
0
+61 416204031
Query!
Fax
82103
0
Query!
Email
82103
0
[email protected]
Query!
Contact person for scientific queries
Name
82104
0
Frances Kay-Lambkin
Query!
Address
82104
0
University of Newcastle
School of Medicine and Public Health
CBMHR
PO Box 833
Newcastle
NSW 2300
Query!
Country
82104
0
Australia
Query!
Phone
82104
0
+61 416204031
Query!
Fax
82104
0
Query!
Email
82104
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF